Jermasek Douglas 4
4 · Unicycive Therapeutics, Inc. · Filed Aug 14, 2024
Insider Transaction Report
Form 4
Jermasek Douglas
EVP of Corporate Strategy
Transactions
- Award
Stock Options
2024-08-12+81,750→ 2,055,000 totalExercise: $0.34Exp: 2034-08-12→ Common Stock (81,750 underlying)
Footnotes (1)
- [F1]20,438 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.